Form 4: AVNS CEO Awarded Equity, Options in Long-Term Plan

AVANOS MEDICAL, INC. CEO David Pacitti received 101,341 restricted share units and 239,354 employee stock options as part of the company's long-term incentive plan.

Summary

• David Pacitti, Chief Executive Officer of AVANOS MEDICAL, INC. (AVNS), was awarded 101,341 time-based restricted share units (TRSUs) on March 13, 2026.
• These TRSUs were granted pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended, and will vest in three equal installments: 1/3 on March 13, 2027, 1/3 on March 13, 2028, and 1/3 on March 13, 2029.
• Each TRSU is economically equivalent to one share of Common Stock, and the acquisition price was $0.
• Additionally, Mr. Pacitti was awarded 239,354 employee stock options on March 13, 2026, with an exercise price of $13.69 per share.
• The stock options will vest 30% on March 13, 2027, 30% on March 13, 2028, and 40% on March 13, 2029, and have an expiration date of March 13, 2036.
• Following these transactions, Mr. Pacitti beneficially owns 343,388 shares of Common Stock and 239,354 derivative securities (employee stock options).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development for corporate governance, as it aligns the CEO's long-term financial interests with those of shareholders through significant equity awards, without indicating any immediate operational or financial changes.

Positives

• The acquisition of significant equity awards by the CEO aligns his long-term financial interests with those of the company's shareholders, promoting sustained value creation.
• The awards are part of a structured Long Term Incentive Plan, indicating a commitment to executive retention and performance-based compensation.

Future Outlook

The multi-year vesting schedules for both the restricted share units and employee stock options indicate a long-term commitment from the CEO to the company's performance and strategic objectives, with full vesting extending through March 2029.

Management Comments

• The awards were granted pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended.

Industry Context

StockSavvy.ai notes that equity awards, such as restricted share units and stock options, are a common and effective practice in the medical device industry to incentivize executive performance, retain key talent, and align management's financial interests with those of shareholders over the long term.

Comparison to Industry Standards

• StockSavvy.ai observes that granting time-based restricted share units and employee stock options with multi-year vesting schedules is a standard practice for executive compensation in the healthcare and medical technology sectors, comparable to incentive structures seen at companies like Medtronic or Stryker, aiming to foster long-term value creation.

Corporate Governance

Related Party Transactions

• Acquisition of equity awards by the Chief Executive Officer from the company, which is a standard related-party compensation event under the company's long-term incentive plan.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of the CEO's financial interests with long-term shareholder value.
• Employees: No direct impact mentioned, but a well-incentivized leadership can contribute to overall company stability and growth.

Next Steps

• Vesting of 1/3 of TRSUs and 30% of employee stock options on March 13, 2027.
• Vesting of 1/3 of TRSUs and 30% of employee stock options on March 13, 2028.
• Vesting of 1/3 of TRSUs and 40% of employee stock options on March 13, 2029.

Key Dates

Recommendation

This Form 4 reports a standard equity award to the CEO, which is a positive for aligning management incentives with shareholder interests. However, it does not present new fundamental information that would warrant a change in investment recommendation based solely on this filing.

Keywords

AVANOS MEDICAL, AVNS, David Pacitti, CEO, Restricted Share Units, RSUs, Stock Options, Equity Award, Insider Transaction, Form 4, Executive Compensation, Long Term Incentive Plan